The Valley Desk

NCT01463306 · Interventional trial

A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures

Overall registry status Completed

Phase 3

Conditions Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov